Company profile: Omiics
1.1 - Company Overview
Company description
- Provider of RNA sequencing solutions and comprehensive NGS services tailored to research needs, including consultation, RNA extraction from tissues and biofluids, sample and library preparation (rRNA depletion, UMI tagging for low-input), sequencing via Illumina, DNBseq, and Oxford Nanopore with long-read, on-site capabilities, plus bioinformatics/data analysis and result interpretation.
Products and services
- Total NGS Solution: Delivers a custom-engineered comprehensive service including consultation, sample preparation, sequencing, bioinformatics analysis, and result interpretation, tailored to specific research needs
- Next Generation Sequencing (NGS): Offers industrial-grade sequencing using Illumina and DNBseq platforms, with selectable sequencer models optimized for capacity and speed to match project requirements
- Third Generation Sequencing: Supplies long-read Oxford Nanopore technologies suitable for on-site sequencing, supporting extended read lengths for projects conducted directly at research sites
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Omiics
Synteract
HQ: United States
Website
- Description: Provider of full-service contract research organization (CRO) solutions focused on emerging biopharma, supporting biotech and pharmaceutical companies across all phases of drug development with multidisciplinary teams and expertise in oncology, dermatology, general medicine, infectious disease and vaccine, and neuroscience; a Syneos Health company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synteract company profile →
Medical Research Network
HQ: United States
Website
- Description: Provider of clinical research studies on mental health, neurological, and chronic pain disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical Research Network company profile →
Scorpius Biologics
HQ: United States
Website
- Description: Provider of integrated CDMO services for biologics, specializing in mammalian, microbial, and cell therapies. Offers biomanufacturing from pre-clinical to commercial, including analytical methods development, process development, cGMP manufacturing, product characterization, QC release testing, formulation development, and analytical testing, supported by a clinical-scale cGMP facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scorpius Biologics company profile →
Regulatory Professionals
HQ: United States
Website
- Description: Provider of regulatory expertise and end-to-end development support to biotechnology, pharmaceutical and medical device companies, including strategic product development, regulatory strategy, submissions and meetings, clinical and PK design, CMC integration and vendor management, nonclinical strategy and studies, and commercial insights to maximize program potential from development through commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regulatory Professionals company profile →
CSL
HQ: United States
Website
- Description: Provider of quality system, risk management, support, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CSL company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Omiics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Omiics
2.2 - Growth funds investing in similar companies to Omiics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Omiics
4.2 - Public trading comparable groups for Omiics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →